I critique Baxter International's capital allocation decisions, stating the stock is not suitable for popular investment strategies. See why I rate BAX a sell.
Greek companies are increasing their investments in Cyprus, drawn by its strategic location, stable economy, and access to Middle Eastern markets. With over 1,500 Greek-affiliated companies operating ...
Novartis expects profit and sales to grow further this year after beating analysts' expectations in the fourth quarter, boosted by revenue from its key drugs.
AlphaCore Wealth Advisory ("AlphaCore"), an independent registered investment advisory (RIA) firm, announced today its partnership with enTrust Wealth Advisors ("enTrust"), an independent registered ...